Skip to main content
Clinical Trials/NCT03066726
NCT03066726
Terminated
Not Applicable

Does the Cerebroplacental Ratio (CPR) Predict Adverse Outcomes in Low Risk Pregnancies?

Rutgers, The State University of New Jersey6 sites in 1 country580 target enrollmentMay 15, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebroplacental Ratio
Sponsor
Rutgers, The State University of New Jersey
Enrollment
580
Locations
6
Primary Endpoint
Cesarean delivery
Status
Terminated
Last Updated
3 years ago

Overview

Brief Summary

Ultrasound Doppler studies are used during pregnancy to help manage pregnancies complicated by fetal growth restriction. The cerebroplacental ratio may predict adverse outcomes in low risk pregnancies. In a prospective study, the investigators will examine whether fetuses with an abnormal CPR at or near term are at increased risk for being delivered by cesarean,

Detailed Description

This is a multicenter prospective study of low-risk nulliparous women who will be recruited if they are having an ultrasound at 36 weeks of estimated gestational age or greater. As part of the study, women will have umbilical and middle cerebral artery Doppler studies and the CPR will be calculated by dividing the middle cerebral artery PI by the umbilical artery PI. Providers caring for study subjects will be blinded to this result. Pregnancy outcomes in women with CPR values less than the 10th percentile for gestational age will be compared to those with CPR values above the 10th percentile. A secondary aim of the study is to analyze CPR as a continuous variable.

Registry
clinicaltrials.gov
Start Date
May 15, 2017
End Date
May 7, 2020
Last Updated
3 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Todd Rosen, MD

Director, Maternal-Fetal Medicine

Rutgers, The State University of New Jersey

Eligibility Criteria

Inclusion Criteria

  • Nulliparous pregnant women between the ages of 18 and 45 years with low risk pregnancies who present for obstetrical ultrasound at 36 weeks of gestation or later with a planned delivery at a Perinatal Research Consortium hospital.

Exclusion Criteria

  • Multifetal pregnancy at the time of presentation
  • Known fetal chromosomal anomaly
  • Known fetal malformation
  • Preeclampsia
  • Fetal growth restriction
  • Multiparity
  • Prior cesarean section
  • Placental abnormalities such as previa or accreta
  • Pregestational diabetes
  • Plan to deliver outside the Perinatal Research Consortium affiliated hospitals

Outcomes

Primary Outcomes

Cesarean delivery

Time Frame: From labor to delivery

Cesarean delivery rate for non reassuring fetal heart tracings

Secondary Outcomes

  • Cases of small for gestational age undetected prenatally(At time of delivery)
  • Cord blood gases(At the time of delivery)
  • Incidence of category 2 or 3 tracings(During labor)
  • Rate of operative vaginal delivery(At time of delivery)
  • Total cesarean section rate(From labor to delivery)
  • Birthweight/ birthweight percentile(At time of delivery)
  • Distribution of CPR by estimated fetal weight(Measured during ultrasound between 36 weeks gestational age and delivery of the pregnancy.)
  • Neonatal Intensive Care Unit admission(Up to 28 days from delivery of the pregnancy)
  • Apgar scores at 1 and 5 minute(Scores assigned at 1 and 5 minutes of life by clinical staff.)
  • Composite neonatal outcome(Up to 28 days from delivery of the pregnancy.)

Study Sites (6)

Loading locations...

Similar Trials